People's Hospital Of Quzhou
Clinical trials sponsored by People's Hospital Of Quzhou, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a gentler chemo combo with delayed immunotherapy tame advanced lung cancer? Results expected Oct 2026 (estimated)
-
Could a gentler chemo combo with delayed immunotherapy tame advanced lung cancer?
Disease control Recruiting nowThis study investigates whether a lower dose of two chemotherapy drugs (carboplatin and nab-paclitaxel) combined with a delayed dose of the immunotherapy serplulimab can effectively treat advanced squamous non-small cell lung cancer. The trial compares this gentler regimen to a s…
Early phase 1 • Sponsor: People's Hospital of Quzhou • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Anti-aging pill tested in 1-year human trial
Disease control Recruiting nowThis study tests whether taking a daily capsule of nicotinamide mononucleotide (NMN) can reduce biological age in healthy adults aged 40-70. Over 240 participants will take either NMN or a placebo for one year. Researchers will measure aging using blood tests and other markers to…
Sponsor: People's Hospital of Quzhou • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC